Loading... 2 0 20 0 false
Borges, Olga
Loading... 3 0 20 0 false


Results 1-26 of 26 (Search time: 0.122 seconds).

Issue DateTitleAuthor(s)TypeAccess
12019Activity and Cell-Death Pathway in Leishmania infantum Induced by Sugiol: Vectorization Using Yeast Cell Wall Particles Obtained From Saccharomyces cerevisiaeScariot, Débora Botura; Volpato, Hélito; Fernandes, Nilma de Souza; Soares, Edna Filipa Pais ; Ueda-Nakamura, Tânia; Dias-Filho, Benedito Prado; Din, Zia Ud; Rodrigues-Filho, Edson; Rubira, Adley Forti; Borges, Olga ; Sousa, Maria Céu ; Nakamura, Celso VataruarticleopenAccess
218-Feb-2016Adjuvant Nanocarriers for Hepatitis B Vaccine: Formulation Design and Mechanistic StudiesJesus, Sandra Cristina Campos de doctoralThesisembargoedAccess
32008Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigenBorges, Olga ; Silva, Marta ; Sousa, Adriano de ; Borchard, Gerrit ; Junginger, Hans E. ; Cordeiro-da-Silva, Anabela articleopenAccess
49-Feb-2017Association of compound 48/80 with chitosan based nanoparticles: designing a novel prototypic delivery system for nasal vaccinationBento, Dulce Marisa Ferreira doctoralThesisembargoedAccess
52020Chitosan Nanoparticles: Shedding Light on Immunotoxicity and HemocompatibilityJesus, Sandra ; Marques, Ana Patrícia ; Duarte, Alana ; Soares, Edna ; Costa, João Panão da ; Colaço, Mariana ; Schmutz, Mélanie; Som, Claudia; Borchard, Gerrit ; Wick, Peter; Borges, Olga articleopenAccess
69-Feb-2019Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine AdjuvantBento, Dulce ; Jesus, Sandra ; Lebre, Filipa ; Gonçalves, Teresa ; Borges, Olga articleopenAccess
72015Desenvolvimento de uma vacina oral contra giarda lambliaPica-Milho, Ana Cláudia FalcãomasterThesisembargoedAccess
8Jul-2015Development and characterization of chitosan based nanoparticles for future applications as delivery systemsCarvalho, Sofia dos SantosotheropenAccess
925-Nov-2017Development of chitosan-based nanoparticles for nasal immunization against hepatitis BLebre, Filipa Raquel Maia Fontes doctoralThesisembargoedAccess (6 years)
102020Editorial: Polymeric Nano-Biomaterials for Medical Applications: Advancements in Developing and Implementation Considering Safety-by-Design ConceptsBorchard, Gerrit ; Som, Claudia; Zinn, Manfred; Ostafe, Vasile; Borges, Olga ; Perale, Giuseppe; Wick, PeterarticleopenAccess
112007Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticlesBorges, Olga ; Tavares, Joana ; Sousa, Adriano de ; Borchard, Gerrit ; Junginger, Hans E. ; Cordeiro-da-Silva, Anabela articleopenAccess
122019Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So FarJesus, Sandra ; Schmutz, Mélanie; Som, Claudia; Borchard, Gerrit ; Wick, Peter; Borges, Olga articleopenAccess
132020How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design ConceptMarques, Cíntia ; Som, Claudia; Schmutz, Mélanie; Borges, Olga ; Borchard, Gerrit articleopenAccess
142008Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticlesBorges, Olga ; Cordeiro-da-Silva, Anabela ; Tavares, Joana ; Santarém, Nuno ; Sousa, Adriano de ; Borchard, Gerrit ; Junginger, Hans E. articleopenAccess
152007Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymersBorges, Olga ; Borchard, Gerrit ; Sousa, Adriano de ; Junginger, Hans E. ; Cordeiro-da-Silva, Anabela articleopenAccess
162013Mucosal vaccination: opportunities and challengesBorges, Olga ; Borchard, Gerrit bookPartopenAccess
172012A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasisOliveira, Carolina R.; Rezende, Cíntia M. F.; Silva, Marina R.; Pêgo, Ana Paula; Borges, Olga ; Goes, Alfredo M.articleopenAccess
1827-Dec-2019Oral treatment with T6-loaded yeast cell wall particles reduces the parasitemia in murine visceral leishmaniasis modelScariot, Débora B.; Volpato, Hélito; Fernandes, Nilma S.; Lazarin-Bidóia, Danielle; Borges, Olga ; Sousa, Maria do Céu ; Rosa, Fernanda A.; Jacomini, Andrey P.; Silva, Sueli O.; Ueda-Nakamura, Tânia; Rubira, Adley F. ; Nakamura, Celso V.articleopenAccess
192019Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its ImmunotoxicitySilva, Jéssica da ; Jesus, Sandra ; Bernardi, Natália; Colaço, Mariana ; Borges, Olga articleopenAccess
202005Preparation of coated nanoparticles for a new mucosal vaccine delivery systemBorges, Olga ; Borchard, Gerrit ; Verhoef, J. Coos ; Sousa, Adriano de ; Junginger, Hans E. articleopenAccess
212006Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccinationBorges, Olga ; Cordeiro-da-Silva, Anabela ; Romeijn, Stefan G. ; Amidi, Maryam ; Sousa, Adriano de ; Borchard, Gerrit ; Junginger, Hans E. articleopenAccess
22Sep-2015Vacina contra o HIVCruz, Miguel OliveiraotheropenAccess
23Sep-2015Vacina contra o vírus Ébola: desafios e perspetivasPereira, Sara Maria Tábuas da CunhaotheropenAccess
24Jul-2014Vacinação contra a hepatite B na doença celíacaSilva, Rita de Agrela Caetano daotheropenAccess
25Sep-2015Vacinas de mRNA: o que são e perspectivas de utilização contra o cancroRego, João Miguel Nogueira otheropenAccess
2611-Sep-2018β-glucan-based adjuvants for Hepatitis B vaccination: particulate design for prophylactic and therapeutic needsSoares, Edna Filipa PaisdoctoralThesisembargoedAccess